Generic drug industry outlook
Mar. 19 - Director of Generics at Thomson Scientific Kate Kuhrt provides insight on the landscape of generic drugs, joined by Healthcare Correspondent Lewis Krauskopf and Carrie Lee.<div class="feedflare">
<img src="http://feeds2.feedburner.com/~ff/reuters/USVideoBusiness?d=yIl2AUoC8zA" border="0"></img> (http://feeds.reuters.com/~ff/reuters/USVideoBusiness?a=-tGzRXs8ZZ4:GAW213gwSQs:yIl2AUoC8zA) <img src="http://feeds2.feedburner.com/~ff/reuters/USVideoBusiness?i=-tGzRXs8ZZ4:GAW213gwSQs:V_sGLiPBpWU" border="0"></img> (http://feeds.reuters.com/~ff/reuters/USVideoBusiness?a=-tGzRXs8ZZ4:GAW213gwSQs:V_sGLiPBpWU) <img src="http://feeds2.feedburner.com/~ff/reuters/USVideoBusiness?i=-tGzRXs8ZZ4:GAW213gwSQs:F7zBnMyn0Lo" border="0"></img> (http://feeds.reuters.com/~ff/reuters/USVideoBusiness?a=-tGzRXs8ZZ4:GAW213gwSQs:F7zBnMyn0Lo)
</div><img src="http://feeds2.feedburner.com/~r/reuters/USVideoBusiness/~4/-tGzRXs8ZZ4" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/USVideoBusiness/~3/-tGzRXs8ZZ4/video